Fortunato R. Rocca insider trades

Open-market stock purchases and sales by Fortunato R. Rocca, Director at Interpace Biosciences, Inc, from SEC Form 4 filings since Sep 18, 2019.

Recent trades

DateStockTradeValue
Aug 20, 2026IDXG Interpace Biosciences, IncBought (not open market)—

Companies traded

  • IDXG Interpace Biosciences, Inc: other filings, last Aug 20, 2026
  • XGN Exagen Inc: other filings, last Mar 1, 2022

Get free alerts when Fortunato R. Rocca files a new trade →